Supraventricular tachycardia
5 papers1 finding
- Humans3
Associations
1Hormone replacement therapy
upin humans1HR 2.33
1 study
Hormone replacement therapy
upin humans1HR 2.33
Hormone replacement therapy raises the risk of supraventricular tachycardia in humans (HR 2.33, 95% CI 2.17-2.51).
“SVT (risk difference 0.014, 95% CI [0.013, 0.016], HR 2.33, 95% CI [2.17, 2.51])”
Humansup to 3 yearsfemalesn = 172,086
Hormone Replacement Therapy and Arrhythmia Risk in Menopause: A Comprehensive Nationwide Analysis
AHA Scientific Sessions 2025 abstract3 Nov 2025
Latest
5 in 12 monthsADA Scientific Sessions 2026 Abstract
Effects of SGLT2 Inhibitors on Cardiac Arrhythmias: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta-analysis of randomised trialsSGLT2 inhibitors
AHA Scientific Sessions 2025 Abstract
Hormone Replacement Therapy and Arrhythmia Risk in Menopause: A Comprehensive Nationwide Analysis
Cohort study of 172,086 peoplePopulations
AHA Scientific Sessions 2025 Abstract
Effect of Glucagon-like peptide-1 Receptor Agonists on Cardiac Arrhythmias: Systematic Review and Meta-analysis
Meta-analysis of randomised trialsGLP-1 receptor agonists
AHA Scientific Sessions 2025 Abstract
Arrhythmias as Early Predictors of CKD: Real-World Evidence from a National Cardio-Kidney-Metabolic Cohort
Cohort study in peopleArrhythmia
AHA Scientific Sessions 2025 Abstract
CKD and CKM Syndrome: Accelerated Progression to Arrhythmias in a National Cohort
Cohort study in peopleArrhythmia